Evolution Biotechnologies | 2017 November
0
archive,date,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-16.4,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Bedford, UK, November 14th 2017 ­Evolution Biotechnologies (www.evolutionbiotech.com), the UK and US-based company extending the use of biological control into medically important areas, today announced the highly positive outcome of the international (PCT) stage search and examination of its key patent filing PCT/GB2016/052455, “Acaricides”. The examination, conducted by the European Patent Office (EPO), confirmed the broad claim to a method of treating or preventing a house dust mite infestation using an acaricidal infectious agent as both novel and inventive. This is a key step towards obtaining broad protection for the work of the company in controlling house dust mites, a major...